4 Fallen Angels on ASX you need to look at now!
Marc Kennis, April 14, 2023
Our own Stuart Roberts shares his insights on 4 “Fallen Angel” stocks on AusBiz.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
4 Fallen Angels on ASX
Stuart suggests that Domino’s (ASX:DMP) serves as an advanced recession indicator, demonstrating strong growth potential as it continually expands its international store count. Although rising mozzarella prices raise concerns, Stuart views this as a temporary setback, with the stock likely to rebound.
Stuart also emphasizes Kogan.com (ASX:KGN) as the “Everything store” for the Southern hemisphere, indicating that both Kogan and its competitors, such as Amazon, have room to grow as logistics infrastructure improves.
In reference to Xero (ASX:XRO), Stuart regards it as the top accounting software for small and medium-sized enterprises, advised by accountants. The company perpetually expands globally and appears expensive due to the market capitalising on its future growth potential.
Wrapping up our Fallen Angels on ASX, Stuart talks about LendLease (ASX:LLC), renowned for multi-year developments, like Barangaroo in Sydney. He asserts that the company possesses a world-leading franchise that the market struggles to properly capitalise on. As COVID-19 and inflation wane, Stuart envisions LendLease’s stock potentially returning to previous levels.
Watch the full interview here!
Stuart Roberts talks about 4 Fallen Angels on ASX
Need solid trading and investment ideas on ASX?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
There’s no credit card needed – the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!
What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…
Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?
Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…
Trump’s Tariffs Are Back in the News—What’s the Impact on Global Supply Chains?
In recent months, the conversation around trade tariffs has re-emerged, with former President Donald Trump’s trade policies making headlines once…